Trial intelligence / Profile preview

Zoledronic Acid or Methylprednisolone in Active Charcot's Neuroarthropathy

NCT03289338Phase 3Completed

Sponsor
Post Graduate Institute of Medical Education and Research
Start
Jun 2016
Primary completion
Dec 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of zoledronic acid, methylprednisolone injection in Charcot neuroarthropathy (CN), sponsored by Post Graduate Institute of Medical Education and Research. Started Jun 2016; status: completed.

02

Drugs

zoledronic acidmethylprednisolone injection
03

Conditions

Charcot neuroarthropathy (CN)

Beyond the preview

Go deeper on NCT03289338.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03289338.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call